In addition to holding the CEO role for EBT, Mr. Carlton is also a Co-Founder and General Partner at Guide Medical Ventures, a seed investment and management consulting firm. Prior to EBT, Mr. Carlton was President & CEO of HUINNO, Inc., a digital healthcare platform company focused on improving the management and costs of hypertension through wearables and software. Prior to HUINNO, Mr. Carlton held multiple positions at Boston Scientific Neuromodulation including Director of New Therapy Development (focused on Pain, Deep Brain Stimulation, Overactive Bladder, and other areas). Mr. Carlton joined Boston Scientific through the acquisition of Intelect Medical where he was Co-Founder and VP of Product Development. Prior to founding Intelect, Mr. Carlton also held various roles at Medtronic where he was co-inventor of the InterStim tined lead and developed InterStim II for OAB. He also served as Director of Engineering at Texcel Medical (now Cirtec Medical). Mr. Carlton holds over 40 patents around electrical stimulation products and therapies. He has dual B.S. degrees in Biomedical Engineering and Engineering Mechanics from The Johns Hopkins University and an MBA from Boston University.
Mike is a product development leader with over 25 years’ experience managing full life cycle medical device product development and commercialization. Mike has expertise in all phases of product development, including clinical inputs, product definition, system architecture, detailed multi-disciplinary product development, V&V testing, regulatory submissions and manufacturing design transfer. Prior to EBT, Mike served as the Director of Engineering for Valtronic, a device design and manufacturing company specializing in complex medical electromechanical systems. Previously, he was the Director of R&D at Nuvectra, Greatbatch Medical/Integer Holding’s neuromodulation spinout company, where he was responsible for the ground-up development and commercialization of a novel 24-channel, fully implantable neurostimulation system with applications in the treatment of chronic pain, overactive bladder, and deep brain applications for movement disorders. Prior to Greatbatch, Mike was the VP of Engineering for BIOMEC, where he grew and managed a startup engineering team through the submission, receipt and execution of over $30M in NIH funding for various product development programs, prior to BIOMEC’s eventual acquisition. Mike earned a B.S degree in Electrical Engineering from Worcester Polytechnic Institute and a M.S. in Biomedical Engineering from Case Western Reserve University.
Mr. Mariash has nearly 20 years’ experience in marketing, leading and growing new businesses. He started his career in management consulting at Charles River Associates, then joined CSL (Australia’s largest biotech), followed by Baxter, and Boston Scientific; with leadership roles in marketing, strategy, and corporate development. Prior to joining EBT, he was the commercial lead for Boston Scientific’s Cosman radiofrequency ablation franchise. He also led Strategy for Boston Scientific’s ~$1B Neuromodulation division for 8 years, and held leadership roles overseeing development of Class II & III devices, digital strategy, business planning, and M&A assessments. He brings a wealth of expertise in neuromodulation, product development, market insights, go-to-market (including digital), and scaling WW commercial operations. Ken has degrees in Business Economics and Biochemistry from Brown University.
Suranjan is a clinical, product development, and commercialization leader with extensive business, technical and scientific experience. He has an established track record of successful ‘concept to market’ clinical development experience across a range of single-use and implantable medical devices, capital equipment, and drug-device combination products. Prior to joining EBT, he held high-level leadership positions in Clinical, Regulatory, and R&D for Cantel Medical, Cogentix Medical, and American Medical Systems (now Boston Scientific). Besides Urology, he has successfully led products through clinical development and commercial introduction for the Cardiology, Peripheral Vascular, Orthopedic/Spine and Infection Prevention and Control spaces and is an inventor on more than 25 patents. Suranjan has M.S. and Ph.D. degrees in Materials Science and Engineering from the University of Delaware, and a Bachelor’s degree in Metallurgical Engineering from the Indian Institute of Technology (BHU).
Dr. Baynham has over 15 years of medical device experience in R&D, intellectual property development, and clinical research, with positions at Johnson & Johnson, Boston Scientific, and Nevro. She also founded Ingenuity Medical Device Research, LLC in 2013 providing intellectual property development, pre-clinical and clinical study development, and medical writing services. Her clinical research experience encompasses Phase 1 (feasibility) to Phase 4 (post-market) studies in cardiovascular (post-MI, angina, and heart failure), cardiovascular & metabolism (pharmaceuticals), and neuromodulation (Vagal nerve stimulation for obesity, transcutaneous Sacral neuromodulation for overactive bladder, transcutaneous peripheral stimulation for obesity, spinal cord stimulation for pain). Tamara is also a patent agent registered to practice at the United States Patent and Trade Organization (USPTO). Tamara currently holds over 40 patents granted by the USPTO in the areas of electrical stimulation and neuromodulation therapies. Dr. Baynham earned her undergraduate degree in Biomedical and Electrical Engineering at Vanderbilt University and her MS and PhD in Biomedical Engineering at The University of Alabama at Birmingham.
Sukumar is Founder and CEO of Toronto-based FourBridges Consulting Inc, focused on value creation with Healthcare and CPG organizations. He advises several Toronto-based start-ups on strategy, growth, geographical diversification & funding. He also serves as advisor to Angel Funds and sits on the boards of several start-ups. He is a partner in Formulate IP, a global Intellectual Property Advisory firm. Sukumar was previously CFO of Consumer division of Johnson & Johnson Inc, Canada, where he played a critical role in driving profitable growth, finance transformation, acquisition and integration. Prior to his move to Consumer Sector in JNJ, Sukumar was a Director at the Janssen Pharmaceutical division of JNJ. He is a Wharton Alumni and CPA, CA.